Stocks › GNPX
Genprex, Inc.
GNPX·Nasdaq·
United States·USD
United States·USD$2.61
-0.11 (-4.04%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
GNPX
Genprex, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GNPXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of GNPX by members of U.S. Congress · 4 on record · 4 in the last 12 months
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $1,001 - $15,000 |
Feb 20, 2026 | Feb 5, 2026 | Filing ↗ |
| Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2026 | Dec 18, 2025 | Filing ↗ |
| Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $1,001 - $15,000 |
Dec 2, 2025 | Nov 7, 2025 | Filing ↗ |
| Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $15,001 - $50,000 |
Nov 12, 2025 | Oct 29, 2025 | Filing ↗ |
Whale Activity
Position changes in GNPX reported for 2026-06-30 by 2 tracked institutional filers
- Increased1
- New0
- Held1
- Decreased0
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 36.4K | $19K | increased |
| BlackRock, Inc. | 188 | $98 | held |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by GNPX insiders, by quarter · Form 4
Recent Insider Transactions
44 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| LONGNECKER BRENT MDirector | Sale | −10 | $1.23 | $12 | Apr 14, 2026 | Form 4 ↗ |
| LONGNECKER BRENT MDirector | Sale | −8 | $1.23 | $10 | Apr 14, 2026 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −7,168 | $2.00 | $14K | Feb 27, 2026 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Tax withholding | −9,330 | $2.00 | $19K | Feb 27, 2026 | Form 4 ↗ |
| Moreno Toscano Jose AntonioDirector | Grant / award | +9,000 | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Grant / award | +28.5K | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Grant / award | +45.0K | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| LONGNECKER BRENT MDirector | Grant / award | +9,000 | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Wilson William R Jr.Director | Grant / award | +9,000 | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −4,500 | $0.23 | $1K | Jun 30, 2025 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Tax withholding | −5,775 | $0.23 | $1K | Jun 30, 2025 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −585 | $0.41 | $240 | Feb 18, 2025 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Tax withholding | −395 | $0.41 | $162 | Feb 18, 2025 | Form 4 ↗ |
| Moreno Toscano Jose AntonioDirector | Grant / award | +4,750 | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Wilson William R Jr.Director | Grant / award | +4,750 | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| LONGNECKER BRENT MDirector | Grant / award | +4,750 | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Grant / award | +29.4K | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Grant / award | +18.3K | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −1,319 | $4.40 | $6K | Feb 18, 2024 | Form 4 ↗ |
| Varner John RodneyChairman, President and CEO · Director | Tax withholding | −2,642 | $4.40 | $12K | Feb 18, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding GNPX · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 25.1K | $20K | 0.00% | May 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 5,950 | $3K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,522 | $1K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 685 | $534 | 0.00% | May 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list GNPX's shares (CUSIP 372446302), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Genprex, Inc. as client
No lobbying filings found naming Genprex, Inc. as the client.
Government Contracts
Federal awards to Genprex, Inc. · USAspending
No federal contract awards found for Genprex, Inc..
U.S. Patents
Recent USPTO applications naming Genprex, Inc.
No USPTO patent applications found for Genprex, Inc..
Annual Financials
From GNPX's 10-K filings · XBRL
No annual XBRL figures on record for GNPX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-22Reverse splitJul 16, 2026
- 1-for-50Reverse splitOct 21, 2025
- 1-for-40Reverse splitFeb 2, 2024
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01, 9.01Other eventsAug 18, 2026
EDGAR ↗ - 8-K · Items 3.01, 9.01Delisting noticeAug 5, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsAug 3, 2026
EDGAR ↗ - 8-K · Items 3.01, 8.01, 9.01Delisting notice · Other eventsJul 30, 2026
EDGAR ↗ - 8-K · Items 3.03, 5.03, 7.01, 8.01, 9.01Modification of rights · Bylaw amendment · Reg FD disclosureJul 14, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 22, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 18, 2026
EDGAR ↗ - 8-K · Items 3.01, 8.01, 9.01Delisting notice · Other eventsJun 12, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsMay 26, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsMay 14, 2026
EDGAR ↗
About Genprex, Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersAUSTIN, TX
IncorporatedTX
SEC CIK0001595248 ↗